Literature DB >> 7593465

Isotype-specific regulation of MHC class II gene expression in human monocytes by exogenous and endogenous tumor necrosis factor.

M Jasiński1, J Wieckiewicz, I Ruggiero, A Pituch-Noworolska, M Zembala.   

Abstract

The control of expression of MHC class II molecules on antigen-presenting cells is important for the induction of immunity, while aberrant expression of these molecules plays a role in the immunopathology of autoimmune diseases. This study explored the role of tumor necrosis factor alpha (TNF) in controlling the level of HLA class II mRNA in human monocytes. Exposure of monocytes to exogenous recombinant TNF (rTNF) selectively up-regulated DR alpha-mRNA but not DP or DQ alpha-mRNA. Inhibitors of TNF synthesis, pentoxifylline (PTX) and thalidomide, inhibited TNF mRNA accumulation in LPS-activated monocytes and down-regulated DR mRNA but not DP or DQ mRNA. The inhibitory effect of anti-TNF monoclonal antibody (MAb) indicated that endogenously generated TNF acted extracellularly. Anti-p75 TNF-R2 receptor and to a lesser extent anti-p55 TNF-R1 MAbs inhibited TNF-mediated up-regulation of DR mRNA and TNF mRNA. Taken together, this implies that endogenously generated TNF plays a role in controlling isotype-specific MHC class II gene expression in human monocytes/macrophages. These results may have some implications for anti-tumor response and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593465     DOI: 10.1007/BF01541088

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  39 in total

1.  Tumour necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex.

Authors:  U Müller; C V Jongeneel; S A Nedospasov; K F Lindahl; M Steinmetz
Journal:  Nature       Date:  1987 Jan 15-21       Impact factor: 49.962

2.  IL-1 and tumor necrosis factor-alpha each up-regulate both the expression of IFN-gamma receptors and enhance IFN-gamma-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1).

Authors:  T Krakauer; J J Oppenheim
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

3.  Induction of macrophage Ia antigen expression by rIFN-gamma and down-regulation by IFN-alpha/beta and dexamethasone are mediated by changes in steady-state levels of Ia mRNA.

Authors:  D Fertsch; D R Schoenberg; R N Germain; J Y Tou; S N Vogel
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

4.  Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide.

Authors:  K Bendtzen; N Morling; A Fomsgaard; M Svenson; B Jakobsen; N Odum; A Svejgaard
Journal:  Scand J Immunol       Date:  1988-11       Impact factor: 3.487

5.  IFN-gamma and lipopolysaccharide differentially modulate expression of tumor necrosis factor receptor mRNA in murine peritoneal macrophages.

Authors:  C S Tannenbaum; J A Major; T A Hamilton
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

6.  A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha.

Authors:  A G Wilson; C Gordon; F S di Giovine; N de Vries; L B van de Putte; P Emery; G W Duff
Journal:  Eur J Immunol       Date:  1994-01       Impact factor: 5.532

7.  Regulation of class II MHC molecules on human endothelial cells. Effects of IFN and dexamethasone.

Authors:  C L Manyak; H Tse; P Fischer; L Coker; N H Sigal; G C Koo
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

8.  Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen, Mo3e.

Authors:  R F Todd; P A Alvarez; D A Brott; D Y Liu
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

9.  An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP.

Authors:  S J Ono; V Bazil; M Sugawara; J L Strominger
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.

Authors:  E P Sampaio; E N Sarno; R Galilly; Z A Cohn; G Kaplan
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  1 in total

1.  Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation.

Authors:  Mehdi Hamadani; Craig C Hofmeister; Buffy Jansak; Gary Phillips; Patrick Elder; William Blum; Sam Penza; Thomas S Lin; Rebecca Klisovic; Guido Marcucci; Sherif S Farag; Steven M Devine
Journal:  Biol Blood Marrow Transplant       Date:  2008-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.